# Study of Microvascular Dysfunction, CFR and Cardioprotective Effect of Early Administration of Esmolol in MI

> **NCT06376630** · NA · RECRUITING · sponsor: **National Medical Research Center for Cardiology, Ministry of Health of Russian Federation** · enrollment: 300 (estimated)

## Conditions studied

- Myocardial Infarction
- Coronary Stenosis
- Coronary Microvascular Dysfunction

## Interventions

- **DRUG:** Esmolol Hcl 10Mg/Ml Inj

## Key facts

- **NCT ID:** NCT06376630
- **Lead sponsor:** National Medical Research Center for Cardiology, Ministry of Health of Russian Federation
- **Sponsor class:** OTHER_GOV
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-01-29
- **Primary completion:** 2029-01-29
- **Final completion:** 2030-01-29
- **Target enrollment:** 300 (ESTIMATED)
- **Last updated:** 2024-04-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06376630

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06376630, "Study of Microvascular Dysfunction, CFR and Cardioprotective Effect of Early Administration of Esmolol in MI". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06376630. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*